HIV Drug That Protects a Fetus Should Be Avoided for One Year After Childbirth, University of Alabama at Birmingham Researchers Say

University of Alabama -- BIRMINGHAM, Ala. - Women given the human immunodeficiency virus (HIV) prevention drug nevirapine to protect their fetus should not use an HIV-drug regimen that contains nevirapine for at least one year after childbirth, say researchers at the University of Alabama at Birmingham (UAB).